Safety surveillance and challenges in accelerated COVID-19 vaccine development.

Cole, Abimbola; Webster, Peggy; Van Liew, Denny; Salas, Maribel; Aimer, Omar; Malikova, Marina A

Cole, Abimbola; Webster, Peggy; Van Liew, Denny; Salas, Maribel; Aimer, Omar; Malikova, Marina A.

Afiliação

Cole A; GSK plc, Brentford UK. MCPHS University, Boston, MA, USA.
Webster P; GSK plc, Brentford, UK.
Van Liew D; Red Nucleus, Yardley, PA, USA.
Salas M; Daiichi Sankyo, Inc., Basking Ridge, New Jersey USA; CCEB/CPeRT, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Aimer O; InnoVigilance, Laval, QC, Canada.
Malikova MA; Surgical Translational Research: Operations and Compliance, Department of Surgery, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.

Ther Adv Drug Saf ; 13: 20420986221116452, 2022.

Article em En | MEDLINE | ID: mdl-36072284

Palavras-chave

COVID-19; equity; pharmacovigilance; safety; vaccine development

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Screening_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Screening_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article